For the first time, we identified that TLR1 rs5743565 might perform as a predisposing risk factor, and TT genotypes carriers were nearly 2.17-time more likely to develop hepatotoxicity based on rifampicin and isoniazid anti-TB compared with patients having CC/CT genotypes. Here, TLR1 is linked to tuberculosis.